|
Q-1057
|
Tuesday, April 14, 2026 |
With regard to the “Subsection 56(1) class exemption in relation to urgent public health need sites in the provinces and territories”, since 2023 and broken down by calendar year: how many urgent public health need sites were operational at any point during the calendar year in each province and territory? |
Awaiting response |
|
|
Q-973
|
Thursday, March 19, 2026 |
With regard to government contracts with advertising agencies, since January 2020, broken down by department or agency and by year: what are the details of each contract, including (i) the name of the advertising agency, (ii) the contract value, (iii) the start and end dates of the contract, (iv) the description of the advertising campaign or the purpose for which the agency was paid, (v) the media or platforms on which the advertising was placed, (vi) whether the contract was awarded through a competitive or non-competitive process, (vii) the description of the services provided? |
Awaiting response |
Wednesday, May 6, 2026 |
|
Q-955
|
Thursday, March 12, 2026 |
With regard to all federal funding provided to MySafe Society since January 2020: (a) what are the details of each contribution, grant and contract, including the (i) department or agency providing the funding, (ii) total value, (iii) start and end dates, (iv) purpose of the funding; (b) for each expenditure in (a), did the agreement require MySafe Society to report to the government on (i) participant health outcomes, (ii) overdose events, (iii) diversion of dispensed substances to unregistered individuals; (c) what reporting, if any, was received by the government under the requirements in (b); (d) was any audit or evaluation of the agreements in (a) conducted, and, if so, what were the findings; (e) what are the details of any federal funding specifically used for the acquisition, installation or operation of drug-dispensing machines, including the (i) number of machines funded, (ii) locations where machines were installed, (iii) total federal contribution toward the machines; and (f) at the time each funding agreement was signed, was the federal government aware that MySafe Society would be using federal funds to dispense opioids through machines, and, if so, (i) which department or official approved the funding with that knowledge, (ii) what controlled substances were known to be dispensed, (iii) what safeguards, if any, were required as a condition of funding? |
Awaiting response |
Wednesday, May 6, 2026 |
|
Q-916
|
Thursday, February 26, 2026 |
With regard to the Interim Federal Health Program, since 2016 and broken down by year: (a) how many asylum claimants, whose claim was ultimately rejected by the Immigration and Refugee Board, received coverage under the program; (b) of the rejected asylum claimants in (a), how many had an active enforceable removal order; and (c) what were the total annual expenditures associated with Interim Federal Health Program coverage provided to rejected asylum claimants, including all services provided over the full course of their claim, broken down by (i) basic health services, (ii) supplemental health services, (iii) immigration medical exams in Canada, (iv) pre-departure medical services? |
Awaiting response |
Wednesday, April 22, 2026 |
|
Q-746
|
Tuesday, December 9, 2025 |
With regard to the $1 million in the Public Health Agency of Canada’s funding for “government advertising programs” in the Supplementary Estimates (B), 2025-26: (a) what are the details of this funding, including, for each advertising campaign, the (i) title or description, (ii) total amount budgeted, (iii) total amount spent, (iv) start and end dates, (v) target audience, (vi) objective of the campaign, (vii) media used (television, radio, print, digital, social media), (viii) location of advertisement? |
Answered |
Monday, January 26, 2026 |
|
Q-745
|
Tuesday, December 9, 2025 |
With regard to visits by the current Minister of Health and senior officials within Health Canada and the Public Health Agency of Canada to supervised consumption sites: (a) how many times has (i) the current Minister of Health, (ii) Deputy Minister of Health Greg Orencsak, (iii) Assistant Deputy Minister of Health Kendal Weber, (iv) President of the Public Health Agency of Canada Nancy Hamzawi, visited supervised consumption sites; (b) for each individual in (a), what were the dates and locations of the supervised consumption site visits; and (c) broken down by each individual and visit, what travel costs were incurred for each trip that was associated with the visit, in total and broken down by type of expense (accommodation, airfare, etc.)? |
Answered |
Monday, January 26, 2026 |
|
Q-738
|
Tuesday, December 9, 2025 |
With regard to protected persons in Canada who were exempted from completing a subsequent immigration medical examination when applying for permanent residence under the Temporary Public Policy and subsequent regulatory amendments, since September 10, 2020, broken down by year: (a) how many applications were subject to additional review by an officer due to (i) concerns related to declared or identified travel history outside Canada, (ii) concerns related to compliance with medical surveillance conditions, (iii) other medical admissibility or program considerations; (b) how many applicants initially considered eligible for the exemption were later determined to be ineligible before a final permanent residence decision was rendered; and (c) of the applicants in (b), how many were determined to be ineligible due to (i) non-compliance with medical surveillance requirements, (ii) time spent outside Canada in a country or territory designated as having a higher incidence of serious communicable disease, (iii) inconsistent, incomplete or inaccurate information related to medical or travel history provided in the application process? |
Answered |
Monday, January 26, 2026 |
|
Q-737
|
Tuesday, December 9, 2025 |
With regard to protected persons in Canada who applied for permanent residence since 2015, broken down by year: (a) how many applicants (i) were required to complete a subsequent immigration medical examination, (ii) were exempted from completing a subsequent immigration medical examination; and (b) of those in (a)(ii), what was the reason for which they were exempted? |
Answered |
Monday, January 26, 2026 |
